RLMD
Relmada Therapeutics, Inc. · Healthcare
Director Charles J Casamento sold $101K of Relmada Therapeutics, Inc.
Sold$100,898
$33.63Price
3,000Shares
−14%Stake
What RLMD did after the filing
- The stock from Tue, Feb 2 close, $35.01
- +4.6%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Mar 17 close.
Traded Mon, Feb 1. Filed Tue, Feb 2, 12:05 PM ET, during the session. Returns use the Feb 2 close and the Mar 17 close. Not investment advice.